(Grabherr et al., 2011). Gene expression levels were then calculated with RSEM (v. 1.2.15). The completeness of the gene assembly was evaluated by BUSCO v. 3.0.2. Transcriptome annotation was ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...